TSOI (Therapeutic Solutions International) EBITDA Margin %: -9,260.00% (As of Sep. 2024)


What is Therapeutic Solutions International EBITDA Margin %?

Therapeutic Solutions International TSOI -99.00% EBITDA Margin % is -9,260.00% as of Sep. 2024.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Therapeutic Solutions International's EBITDA for the three months ended in Sep. 2024 was $-1.85 Mil. Therapeutic Solutions International's Revenue for the three months ended in Sep. 2024 was $0.02 Mil. Therefore, Therapeutic Solutions International's EBITDA margin for the quarter that ended in Sep. 2024 was -9,260.00%.

Therapeutic Solutions International  (OTCPK:TSOI) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Therapeutic Solutions International EBITDA Margin % Related Terms

Therapeutic Solutions International EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for Therapeutic Solutions International's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therapeutic Solutions International EBITDA Margin % Chart

Therapeutic Solutions International Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -4,962.96 -3,000.00 -1,596.58 -1,442.51 -1,502.02

Therapeutic Solutions International Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1,703.85 -1,258.33 -2,718.18 -1,565.00 -9,260.00

TSOI vs BPTH, RGBP, HEPA: EBITDA Margin % Comparison

For the Biotechnology subindustry, Therapeutic Solutions International's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Therapeutic Solutions International EBITDA Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Therapeutic Solutions International's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Therapeutic Solutions International's EBITDA Margin % falls into.


Therapeutic Solutions International EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Therapeutic Solutions International's EBITDA Margin % for the fiscal year that ended in Dec. 2023 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-1.487/0.099
=-1,502.02 %

Therapeutic Solutions International's EBITDA Margin % for the quarter that ended in Sep. 2024 is calculated as

EBITDA Margin %=EBITDA (Q: Sep. 2024 )/Revenue (Q: Sep. 2024 )
=-1.852/0.02
=-9,260.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA Margin % →
What does a EBITDA Margin % of -9,260.00% mean?
Therapeutic Solutions International (TSOI) has a EBITDA Margin % of -9,260.00% as of Sep. 2024. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Therapeutic Solutions International and its competitors.
Is Therapeutic Solutions International's EBITDA Margin % too high?
Therapeutic Solutions International's current EBITDA Margin % is -9,260.00%.
How does Therapeutic Solutions International's EBITDA Margin % compare to BPTH and RGBP?
Therapeutic Solutions International's EBITDA Margin % of -9,260.00% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Biotechnology company?
A good EBITDA Margin % depends on the Biotechnology industry context. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Therapeutic Solutions International and its competitors. Therapeutic Solutions International's current EBITDA Margin % is -9,260.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Therapeutic Solutions International stock overvalued right now?
Therapeutic Solutions International (TSOI) has a current EBITDA Margin % of -9,260.00%. The current EBITDA Margin % is -9,260.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Therapeutic Solutions International (TSOI), the current EBITDA Margin % is -9,260.00% as of Sep. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Therapeutic Solutions International Business Description

Address 701 Wild Rose Lane, Elk City, ID, USA, 83525
Therapeutic Solutions International Inc focuses on immune modulation for the treatment of several specific diseases. It is engaged in developing a range of immune-modulatory agents to target certain cancers, improve maternal and fetal health, fight periodontal disease, and for daily health. The business divisions of the company are Nutraceutical Division which produces nutraceuticals. Its current product, QuadraMune, is a patented synergistic blend of pterostilbene, sulforaphane, epigallocatechingallate, and thymoquionone. Cellular Division obtained exclusive rights to a patented adult stem cell for the development of therapeutics in the area of chronic traumatic encephalopathy and traumatic brain injury and Lung Pathology.